The company's FDA-cleared Percutaneous Nerve Field Stimulator (PNFS) called S.T. Genesis targets the areas of the brain responsible for pain and anxiety, helping patients transition to longer-term treatment. Speranza Therapeutics also distributes orphan drugs and medical devices to provide treatment options for patients with chronic illnesses. Their goal is to remove challenges in delivering treatment to patients in need through proven, clinically effective therapeutics and technology. S.T. Genesis will partner with treatment centers to provide clinical technology, protocols, patient support, and reimbursement services to combat the opioid crisis. Visit their website to learn more.